Close

Albany Molecular Research (AMRI) Higher After Completing Oso Biopharmaceuticals Deal

July 2, 2014 10:28 AM EDT Send to a Friend
Albany Molecular Research, Inc. (NASDAQ: AMRI) is seeing notable upside on strong volume. Overnight ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login